Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Nature
|
November 3, 1972
Sex-hormone-binding globulin is an oestrogen amplifier
C W Burke, D C Anderson
Clinical Endocrinology
|
June 1, 1989
Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH
J S Bevan, C W Burke
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1976
Triiodothyronine and thyroxine in urine. II. Renal handling, and effect of urinary protein
C W Burke, R A Shakespear
The Quarterly Journal of Medicine
|
January 1, 1973
Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis
C W Burke, C G Beardwell
British Journal of Neurosurgery
|
January 1, 1993
Current modes of treatment of pituitary tumours
C B Adams, C W Burke
Journal of the Royal Society of Medicine
|
August 1, 1986
Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndrome
D J Evans, C W Burke
Clinical Endocrinology
|
November 1, 1986
Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptine
J S Bevan, C W Burke
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1976
Triiodothyronine and thyroxine in urine. I. Measurement and application
R A Shakespear, C W Burke
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 9, 1980
Serum concentrations of 3,3',5'-triiodothyronine (reverse T3) in normal pregnancy
E Cooper, C M Aickin, C W Burke
Annals of Clinical Biochemistry
|
November 1, 1986
Sensitive and specific bromocriptine radioimmunoassay with iodine label: measurement of bromocriptine in human plasma
J S Bevan, D Baldwin, C W Burke
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Nature
|
November 3, 1972
Sex-hormone-binding globulin is an oestrogen amplifier
C W Burke, D C Anderson
Clinical Endocrinology
|
June 1, 1989
Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH
J S Bevan, C W Burke
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1976
Triiodothyronine and thyroxine in urine. II. Renal handling, and effect of urinary protein
C W Burke, R A Shakespear
The Quarterly Journal of Medicine
|
January 1, 1973
Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis
C W Burke, C G Beardwell
British Journal of Neurosurgery
|
January 1, 1993
Current modes of treatment of pituitary tumours
C B Adams, C W Burke
Journal of the Royal Society of Medicine
|
August 1, 1986
Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndrome
D J Evans, C W Burke
Clinical Endocrinology
|
November 1, 1986
Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptine
J S Bevan, C W Burke
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1976
Triiodothyronine and thyroxine in urine. I. Measurement and application
R A Shakespear, C W Burke
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 9, 1980
Serum concentrations of 3,3',5'-triiodothyronine (reverse T3) in normal pregnancy
E Cooper, C M Aickin, C W Burke
Annals of Clinical Biochemistry
|
November 1, 1986
Sensitive and specific bromocriptine radioimmunoassay with iodine label: measurement of bromocriptine in human plasma
J S Bevan, D Baldwin, C W Burke
Page
of 8